Milesight UR32L 32.3.0.5 Network Request zebra vlan_name os command injection
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.0 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as critical, was found in Milesight UR32L 32.3.0.5. Affected by this vulnerability is the function vlan_name of the file zebra of the component Network Request Handler. Executing a manipulation can lead to os command injection.
This vulnerability is registered as CVE-2023-25583. It is possible to launch the attack remotely. Furthermore, an exploit is available.
Details
A vulnerability classified as critical was found in Milesight UR32L 32.3.0.5. This vulnerability affects the function vlan_name of the file zebra of the component Network Request Handler. The manipulation with an unknown input leads to a os command injection vulnerability. The CWE definition for the vulnerability is CWE-78. The product constructs all or part of an OS command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended OS command when it is sent to a downstream component. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
Two OS command injection vulnerabilities exist in the zebra vlan_name functionality of Milesight UR32L v32.3.0.5. A specially crafted network request can lead to command execution. An attacker can send a network request to trigger these vulnerabilities.This command injection is in the code branch that manages a new vlan configuration.
The weakness was published 07/06/2023 as TALOS-2023-1723. The advisory is shared for download at talosintelligence.com. This vulnerability was named CVE-2023-25583 since 02/07/2023. Technical details and also a public exploit are known. The MITRE ATT&CK project declares the attack technique as T1202.
It is possible to download the exploit at talosintelligence.com. It is declared as proof-of-concept.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 7.2VulDB Meta Temp Score: 7.0
VulDB Base Score: 7.2
VulDB Temp Score: 6.5
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 7.2
NVD Vector: 🔍
CNA Base Score: 7.2
CNA Vector (Talos): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Os command injectionCWE: CWE-78 / CWE-77 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
02/07/2023 🔍07/06/2023 🔍
07/06/2023 🔍
11/06/2025 🔍
Sources
Advisory: TALOS-2023-1723Status: Not defined
CVE: CVE-2023-25583 (🔍)
GCVE (CVE): GCVE-0-2023-25583
GCVE (VulDB): GCVE-100-233200
scip Labs: https://www.scip.ch/en/?labs.20161013
Entry
Created: 07/06/2023 18:32Updated: 11/06/2025 08:46
Changes: 07/06/2023 18:32 (54), 11/06/2025 08:46 (25)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.